Commentary

Article

State of Science Summit - Lung Cancer: Chaired by Shetal Patel, MD, PhD

In Partnership With:

State of Science Summit - Lung Cancer: Chaired by Shetal Patel, MD, PhD

State of Science Summit - Lung Cancer: Chaired by Shetal Patel, MD, PhD

Speakers

  • Shetal Patel, MD, PhD | UNC Lineberger Comprehensive Cancer Center
  • Jared Weiss, MD | UNC Lineberger Comprehensive Cancer Center
  • Gita Mody, MD, MPH | UNC Lineberger Comprehensive Cancer Center
  • Neal Reddy, MD | Duke University Hospital
  • Michael Kelley, MD | Duke University and Durham VA Medical Centers
  • Jason Long, MD, MPH | UNC Lineberger Comprehensive Cancer Center

Topics

  • The Latest in Treating SCLC
  • Treatment Crossroad: Neoadjuvant and Adjuvant Immunotherapy in mNSCLC
  • Navigating Immunotherapies in Advanced or mNSCLC
  • Adjuvant to Metastatic: Exploring Targeted Agents for mNSCLC
  • Managing VA Patients with Lung Cancer
  • Updates in Lung Cancer Screening

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Related Videos
Erminia Massarelli, MD, PhD, MS
Karen L. Reckamp, MD, MS
Jacob Sands, MD, oncology medical director, International Patient Center, Dana-Farber Cancer Institute; assistant professor, Harvard Medical School
Fred R. Hirsch, MD, PhD, executive director, Center for Thoracic Oncology, The Tisch Cancer Institute at Mount Sinai; Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
A panel of 4 experts on lung cancer
A panel of 4 experts on lung cancer
Related Content
Antonio Passaro, MD, PhD, medical oncologist, Division of Thoracic Oncology, European Institute of Oncology
July 26th 2024

CHMP Recommends Amivantamab Plus Chemo for Pretreated EGFR+ Advanced NSCLC

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

Jonathan W. Riess, MD, MS
July 26th 2024

Experts Weigh in on Topic of Frontline Osimertinib Alone or With Chemo in EGFR-Mutant NSCLC

Yara Abdou, MD
December 7th 2023

Abdou Spotlights Factors Influencing ADC Treatment Selection in Breast Cancer

ODAC Votes to Require Within Trial Assessment of Neoadjuvant vs Adjuvant Treatment Benefit in Perioperative Trial Protocols in Resectable NSCLC
July 25th 2024

ODAC Votes to Require Within Trial Assessment of Neoadjuvant vs Adjuvant Treatment Benefit in Perioperative Trial Protocols in Resectable NSCLC

Lisa Conte
July 23rd 2024

Crofelemer Misses Diarrhea End Point in Patients With Solid Tumors Receiving Targeted Therapy